News
The “Top 10” list of best-selling gene therapies published by Genetic Engineering & Biotechnology News (GEN) in their May 2025 issue features three products based upon license agreements for technologies originating from the NIH Intramural Research Program. Featured and ranked on the GEN list are
The National Institutes of Health (NIH) announced $20 million in funding from the Stimulating Peripheral Activity to Relieve Conditions (SPARC) awards program. This program aims to transform our understanding of these nerve-organ interactions and ultimately advance the neuromodulation field toward
The 2017 Deals of Distinction™ Award was presented to National Institutes of Health, (NIH) along with its corporate partners, AbbVie and Biogen, for a license agreement related to the development and launch of Zinbryta® for treatment of relapsing multiple sclerosis (MS) The award, one of the most
The National Institutes of Health has several grants to fight tick-borne diseases caused by flaviviruses and bacteria such as Borrelia miyamotoi. Recently, the Laboratory of Medical Zoology’s (LMZ) TickReport service at the University of Massachusetts Amherst, L2 Diagnostics of New Haven, a biotech